StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

<< Previous

Bullboard Posts

Next >>

Post by SAGDollaron Nov 29, 2020 7:48pm

848 Views

Post# 31997856

Views on posts.

Even the view number on posts is up quite a bit on here. Morally less that 200 and now they are 350-500 on a couple day old ones. I think a lot of eyes are here and I wouldn't be surprised to see the break out we expected weeks ago to happen in the near future. I look forward to the CC and seeing this over a buck!

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China